
Jonathan D. Armstrong
Examiner (ID: 4864, Phone: (571)270-7339 , Office: P/3645 )
| Most Active Art Unit | 3645 |
| Art Unit(s) | 3645 |
| Total Applications | 503 |
| Issued Applications | 231 |
| Pending Applications | 107 |
| Abandoned Applications | 202 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18510102
[patent_doc_number] => 20230226202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => IL-2/IL15 COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/916363
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 527
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916363
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916363 | IL-2/IL15 COMPOSITIONS AND METHODS OF USE THEREOF | Mar 28, 2021 | Pending |
Array
(
[id] => 19808329
[patent_doc_number] => 12239688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/209047
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 330
[patent_figures_cnt] => 481
[patent_no_of_words] => 74475
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209047
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/209047 | IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereof | Mar 21, 2021 | Issued |
Array
(
[id] => 16962929
[patent_doc_number] => 20210214428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => IMMUNE CHECKPOINT THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/204564
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204564
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204564 | IMMUNE CHECKPOINT THERAPY | Mar 16, 2021 | Abandoned |
Array
(
[id] => 16930855
[patent_doc_number] => 20210196744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => COMPOSITIONS FOR CANCER THERAPY AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/179301
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179301
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/179301 | COMPOSITIONS FOR CANCER THERAPY AND METHODS | Feb 17, 2021 | Abandoned |
Array
(
[id] => 16930855
[patent_doc_number] => 20210196744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => COMPOSITIONS FOR CANCER THERAPY AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/179301
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179301
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/179301 | COMPOSITIONS FOR CANCER THERAPY AND METHODS | Feb 17, 2021 | Abandoned |
Array
(
[id] => 17186404
[patent_doc_number] => 20210333289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => METHODS OF DETECTING AND TREATING AIRWAY INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/173967
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173967
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/173967 | Methods of detecting and treating airway inflammatory diseases | Feb 10, 2021 | Issued |
Array
(
[id] => 17035101
[patent_doc_number] => 20210252059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => ENGINEERED SAFETY IN CELL THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/173504
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173504
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/173504 | Engineered safety in cell therapy | Feb 10, 2021 | Issued |
Array
(
[id] => 17035184
[patent_doc_number] => 20210252142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/168554
[patent_app_country] => US
[patent_app_date] => 2021-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17168554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/168554 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS | Feb 4, 2021 | Abandoned |
Array
(
[id] => 16854955
[patent_doc_number] => 20210155700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => ANTI-DEspR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/158157
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60468
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17158157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/158157 | ANTI-DEspR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY | Jan 25, 2021 | Abandoned |
Array
(
[id] => 18802374
[patent_doc_number] => 11835530
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Detection of microparticle-associated proteins associated with spontaneous preterm birth
[patent_app_type] => utility
[patent_app_number] => 17/153735
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15988
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153735
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/153735 | Detection of microparticle-associated proteins associated with spontaneous preterm birth | Jan 19, 2021 | Issued |
Array
(
[id] => 16848192
[patent_doc_number] => 20210148937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
[patent_app_type] => utility
[patent_app_number] => 17/153200
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 138337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 290
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153200
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/153200 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | Jan 19, 2021 | Abandoned |
Array
(
[id] => 17300926
[patent_doc_number] => 20210396765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => DETECTION AND TREATMENT OF IL-17 AND IL-13 RELATED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/152331
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152331
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/152331 | DETECTION AND TREATMENT OF IL-17 AND IL-13 RELATED CONDITIONS | Jan 18, 2021 | Abandoned |
Array
(
[id] => 16791750
[patent_doc_number] => 20210121567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => PROTEIN FORMULATIONS AND METHODS OF MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 17/137201
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137201
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/137201 | Protein formulations and methods of making same | Dec 28, 2020 | Issued |
Array
(
[id] => 17266430
[patent_doc_number] => 11191834
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Protein formulations and methods of making same
[patent_app_type] => utility
[patent_app_number] => 17/137246
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 60602
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137246
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/137246 | Protein formulations and methods of making same | Dec 28, 2020 | Issued |
Array
(
[id] => 16688350
[patent_doc_number] => 20210070826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/952861
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 166511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952861
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952861 | Multi-chain chimeric polypeptides and uses thereof | Nov 18, 2020 | Issued |
Array
(
[id] => 19225449
[patent_doc_number] => 12005079
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Biologically relevant orthogonal cytokine/receptor pairs
[patent_app_type] => utility
[patent_app_number] => 16/953000
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 53
[patent_no_of_words] => 16134
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16953000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/953000 | Biologically relevant orthogonal cytokine/receptor pairs | Nov 18, 2020 | Issued |
Array
(
[id] => 17213176
[patent_doc_number] => 20210346512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => LY75 AS CANCER THERAPEUTIC AND DIAGNOSTIC TARGET
[patent_app_type] => utility
[patent_app_number] => 16/951023
[patent_app_country] => US
[patent_app_date] => 2020-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33441
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16951023
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/951023 | LY75 AS CANCER THERAPEUTIC AND DIAGNOSTIC TARGET | Nov 17, 2020 | Abandoned |
Array
(
[id] => 16807894
[patent_doc_number] => 20210130447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF DUCHENNE'S MUSCULAR DYSTROPHY
[patent_app_type] => utility
[patent_app_number] => 17/084686
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17084686
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/084686 | DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF DUCHENNE'S MUSCULAR DYSTROPHY | Oct 29, 2020 | Abandoned |
Array
(
[id] => 18637374
[patent_doc_number] => 11761967
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Methods and compositions for diagnosis and prognosis of renal injury and renal failure
[patent_app_type] => utility
[patent_app_number] => 17/085351
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104245
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/085351 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | Oct 29, 2020 | Issued |
Array
(
[id] => 16658661
[patent_doc_number] => 20210055298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
[patent_app_type] => utility
[patent_app_number] => 17/085566
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23414
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085566
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/085566 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | Oct 29, 2020 | Issued |